Literature DB >> 1323940

Linkage of hyperkalaemic periodic paralysis in quarter horses to the horse adult skeletal muscle sodium channel gene.

J A Rudolph1, S J Spier, G Byrns, E P Hoffman.   

Abstract

A genetic disease observed in certain Quarter horses is hyperkalaemic periodic paralysis (HYPP). This disease causes attacks of paralysis which can be induced by ingestion of potassium. Recent studies have shown that HYPP in humans is due to single base changes within the adult skeletal muscle sodium channel gene. A large Quarter horse pedigree segregating dominant HYPP was studied to determine if mutations of the sodium channel gene are similarly responsible for HYPP in horses. We used cross-species, PCR-mediated, cDNA cloning and sequencing of the horse adult skeletal muscle sodium channel alpha-subunit gene to identify a polymorphism, and then used this polymorphism to see if the horse sodium channel gene was genetically linked to HYPP in horses. The sodium channel gene was indeed found to be tightly linked to HYPP (LOD = 2.7, theta = 0). Our results suggest that HYPP in horses involves the same gene as the clinically similar human disease, and indicates that these are homologous disorders. The future identification of the specific sodium channel mutation causing HYPP in Quarter horses will permit the development of accurate molecular diagnostics of this condition, as has been recently shown for humans.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1323940     DOI: 10.1111/j.1365-2052.1992.tb00136.x

Source DB:  PubMed          Journal:  Anim Genet        ISSN: 0268-9146            Impact factor:   3.169


  10 in total

1.  Molecular genetic and genetic correlations in sodium channelopathies: lack of founder effect and evidence for a second gene.

Authors:  J Wang; J Zhou; S M Todorovic; W G Feero; F Barany; R Conwit; I Hausmanowa-Petrusewicz; A Fidzianska; K Arahata; H B Wessel
Journal:  Am J Hum Genet       Date:  1993-06       Impact factor: 11.025

Review 2.  Equine clinical genomics: A clinician's primer.

Authors:  M M Brosnahan; S A Brooks; D F Antczak
Journal:  Equine Vet J       Date:  2010-10       Impact factor: 2.888

Review 3.  Equine hyperkalemic periodic paralysis: review and implications.

Authors:  J M Naylor
Journal:  Can Vet J       Date:  1994-05       Impact factor: 1.008

4.  Equine motor neuron disease in 2 horses from Saskatchewan.

Authors:  Michelle L Husulak; Katharina L Lohmann; Kamal Gabadage; Chris Wojnarowicz; Fernando J Marqués
Journal:  Can Vet J       Date:  2016-07       Impact factor: 1.008

5.  Targeted analysis of four breeds narrows equine Multiple Congenital Ocular Anomalies locus to 208 kilobases.

Authors:  Lisa S Andersson; Katarina Lyberg; Gus Cothran; David T Ramsey; Rytis Juras; Sofia Mikko; Björn Ekesten; Susan Ewart; Gabriella Lindgren
Journal:  Mamm Genome       Date:  2011-04-05       Impact factor: 2.957

6.  Equine Multiple Congenital Ocular Anomalies maps to a 4.9 megabase interval on horse chromosome 6.

Authors:  Lisa S Andersson; Rytis Juras; David T Ramsey; Jessica Eason-Butler; Susan Ewart; Gus Cothran; Gabriella Lindgren
Journal:  BMC Genet       Date:  2008-12-19       Impact factor: 2.797

7.  Next generation sequencing gives an insight into the characteristics of highly selected breeds versus non-breed horses in the course of domestication.

Authors:  Julia Metzger; Raul Tonda; Sergi Beltran; Lídia Agueda; Marta Gut; Ottmar Distl
Journal:  BMC Genomics       Date:  2014-07-04       Impact factor: 3.969

Review 8.  Mutation discovery for Mendelian traits in non-laboratory animals: a review of achievements up to 2012.

Authors:  Frank W Nicholas; Matthew Hobbs
Journal:  Anim Genet       Date:  2013-12-26       Impact factor: 3.169

9.  Functionally Annotating Regulatory Elements in the Equine Genome Using Histone Mark ChIP-Seq.

Authors:  N B Kingsley; Colin Kern; Catherine Creppe; Erin N Hales; Huaijun Zhou; T S Kalbfleisch; James N MacLeod; Jessica L Petersen; Carrie J Finno; Rebecca R Bellone
Journal:  Genes (Basel)       Date:  2019-12-18       Impact factor: 4.096

10.  Commercial genetic testing for type 2 polysaccharide storage myopathy and myofibrillar myopathy does not correspond to a histopathological diagnosis.

Authors:  Stephanie J Valberg; Carrie J Finno; Marisa L Henry; Melissa Schott; Deborah Velez-Irizarry; Sichong Peng; Erica C McKenzie; Jessica L Petersen
Journal:  Equine Vet J       Date:  2020-10-29       Impact factor: 2.888

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.